Adastra Labs Holdings Ltd. (CSE:XTRX) its shares will commence trading under the symbol XTRX today.
Adastra Labs Holdings Ltd. (CSE:XTRX) (formerly Arrowstar Resources Ltd. (“Adastra” or the “Company”) is pleased to announce the Canadian Securities Exchange (the “CSE”) has approved the listing of its shares on the CSE. Effective January 6, 2020 the shares will commence trading under the symbol XTRX.
About Adastra Labs Holdings Ltd.
Adastra (through its wholly owned subsidiaries, Adastra Labs Inc. and Chemia Analytics Inc.) is in the application process to become a Standard Processor and has received an Analytical Testing Licence from Health Canada under the Cannabis Act and Cannabis Regulations , with licences to produce cannabis extracts and provide third party analytical testing services. These licences will further enable Adastra and its subsidiaries to produce, package, sell (wholesale), and export medically focused and recreational cannabis extract and concentrate products in Canada to other licensed entities and internationally in jurisdictions where medical cannabis extraction products are legal.
The Company’s operations include a facility in British Columbia, Canada. The Company has developed its 13,035 square feet facility to be fully devoted to standard processing and laboratory testing, from which it expects to produce significant amounts of cannabis oil and/or hemp oil and related concentrate products for the Canadian wholesale medical and recreational markets.
The Company intends to offer a suite of unique products under several existing consumer-focused brands, including tinctures, medicinal oils, concentrates, gel capsules and vaporizer pens. Through acquisition of existing cannabis extraction brands and careful development of its new brands, Adastra is working to position itself to become a leader in branded, commercialized products in both the medical and adult-use markets across North America and internationally.
For more information, please contact:
Adastra Labs Holdings Ltd.
Stephen Brohman, CFO and Director – firstname.lastname@example.org
On Behalf of the Board of Directors,
Adastra Labs Holdings Ltd.
CEO and Director
Forward-Looking Statements: This document includes forward-looking statements. Forward-looking statements include, but are not limited to, statements concerning the Company’s transaction. When used in this document, the words such as “could,” “plan,” “estimate,” “expect,” “intend,” “may,” “potential,” “should,” and similar expressions are forward-looking statements. Although Adastra believes that its expectations reflected in these forward-looking statements are reasonable, such statements involve risks and uncertainties and no assurance can be given that actual results will be consistent with these forward-looking statements. Important factors that could cause actual results to differ from these forward-looking statements are disclosed under the heading “Risk Factors” and elsewhere in the corporation’s periodic filings with Canadian securities regulators.